Plasmatic Levels of HSP90α at Diagnosis: A Novel Prognostic Indicator of Clinical Outcome in Advanced Lung Cancer Patients Treated With PD-1/PD-L1 Inhibitors Plus Chemotherapy

por Chen, Shubin, Yu, Qitao, Zhou, Shaozhang
Publicado 2021

Clinicopathological Characteristics And EGFR-TKIs Efficacies In Lung Squamous Cell Carcinoma Patients Harboring An EGFR Sensitizing Mutation

por Zhou, Shaozhang, Wang, Huilin, Jiang, Wei, Yu, Qitao
Publicado 2019

Correlation between KRAS mutation subtypes and prognosis in Chinese advanced non‐squamous non‐small cell lung cancer patients

por Liu, Feiwen, Wang, Fang, He, Jianbo, Zhou, Shaozhang, Luo, Min
Publicado 2023

Effectiveness and Safety of S-1-Based Therapy Compared with 5-Fluorouracil-Based Therapy for Advanced Colorectal Cancer: A Meta-Analysis

por Ye, Jiaxiang, Chen, Jiawei, Ge, Lianying, Liu, Aiqun, Zhou, Shaozhang
Publicado 2014

Prognostic Value of Pretreatment Albumin-to-Alkaline Phosphatase Ratio in Extensive-Disease Small-Cell Lung Cancer: A Retrospective Cohort Study

por Zhou, Shaozhang, Wang, Huiling, Jiang, Wei, Yu, Qitao, Zeng, Aiping
Publicado 2020

Predictive value of pretreatment albumin‐to‐alkaline phosphatase ratio for overall survival for patients with advanced non‐small cell lung cancer

por Zhou, Shaozhang, Jiang, Wei, Wang, Huilin, Wei, Ni, Yu, Qitao
Publicado 2020

A Retrospective Cohort Study on Pretreated Neutrophil-to-Lymphocyte Ratio and Prognosis of Small Cell Lung Cancer: Evidence of Effect Modification by Chemotherapy Regimen

por Liu, Feiwen, Zhou, Shaozhang, Tan, Liping, Jiang, Huiqin, Huang, Yucong
Publicado 2020

The benefit and risk of PD-1/PD-L1 inhibitors plus anti-angiogenic agents as second or later-line treatment for patients with advanced non-small-cell lung cancer: a systematic revi...

por Chen, Shubin, Mo, Wanying, Jiang, Wei, Zhou, Shaozhang, Gan, Haijie, Yu, Qitao
Publicado 2023

Pretreatment plasma d-dimer levels as an independent prognostic factor for overall survival among patients with advanced non-small-cell lung cancer

por Liu, Qianfei, He, Jianbo, Ning, Ruiling, Tan, Liping, Zeng, Aiping, Zhou, Shaozhang
Publicado 2020

Comparison of Different EGFR Gene Mutation Status in Patients with Metastatic Non-Small Lung Cancer After First-Line EGFR-TKIs Therapy and Analyzing Its Relationship with Efficacy...

por Yuan, Chengliang, Jiang, Huiqin, Jiang, Wei, Wang, Huilin, Su, Cuiyun, Zhou, Shaozhang
Publicado 2021

The Association between Pretreatment anemia and Overall Survival in Advanced Non-small Cell lung Cancer: A Retrospective Cohort Study Using Propensity Score Matching

por Huang, Yucong, Su, Cuiyun, Jiang, Huiqin, Liu, Feiwen, Yu, Qitao, Zhou, Shaozhang
Publicado 2022

Pretreatment Fibrinogen-Albumin Ratio (FAR) Associated with Treatment Response and Survival in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Anti-PD-1 Therap...

por Yuan, Chengliang, Huang, Meifang, Wang, Huilin, Jiang, Wei, Su, Cuiyun, Zhou, Shaozhang
Publicado 2022

Prognostic Value of the Glasgow Prognostic Score on Overall Survival in patients with Advanced Non-Small Cell Lung Cancer

por Pan, Mingmei, Zhao, Yun, He, Jianbo, Wu, Huanqiong, Pan, Yujia, Yu, Qitao, Zhou, Shaozhang
Publicado 2021

Predictive value of tumor genetic alteration profiling for chemotherapy and EGFR-TKI treatment in advanced NSCLC

por Jiang, Wei, Zeng, Aiping, Ning, Ruiling, Zhao, Wenhua, Su, Cuiyun, Wang, Huilin, Zhou, Shaozhang, Yu, Qitao
Publicado 2020

The predictive value of pretreatment haemoglobin-to-red cell distribution width ratio for overall survival of patients with advanced non-small cell lung cancer: a propensity score...

por Jiang*, Huiqin, Jiang*, Wei, Tan, Liping, Yu, Qitao, Liu, Feiwen, Huang, Yucong, He, Jianbo, Zhou, Shaozhang
Publicado 2021

The Effect of PD-1 Inhibitor Combined with Chemotherapy on the Level of Peripheral Blood T Lymphocytes among Patients with Non-Small-Cell Lung Cancer and Its Relationship with Prog...

por Zhao, Yun, He, Jianbo, Zhou, Shaozhang, Ning, Ruiling, Zhao, Wenhua, Wang, Huilin, Su, Cuiyun, Jiang, Wei, Zhong, Xiaoning, Yu, Qitao
Publicado 2022

PD-1/PD-L1 inhibitors plus anti-angiogenic agents with or without chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy as second or later-line treatment for patients with ad...

por Chen, Shubin, Wei, Haowen, Zhao, Wenhua, Jiang, Wei, Ning, Ruiling, Zhou, Shaozhang, Tan, Liping, Wang, Huilin, Su, Cuiyun, He, Jianbo, Zeng, Aiping, Zhao, Yun, Yu, Qitao
Publicado 2022

Toripalimab Plus Chemotherapy for Patients With Treatment-Naive Advanced Non–Small-Cell Lung Cancer: A Multicenter Randomized Phase III Trial (CHOICE-01)

por Wang, Zhijie, Wu, Lin, Li, Baolan, Cheng, Ying, Li, Xiaoling, Wang, Xicheng, Han, Liang, Wu, Xiaohong, Fan, Yun, Yu, Yan, Lv, Dongqing, Shi, Jianhua, Huang, Jianjin, Zhou, Shaozhang, Han, Baohui, Sun, Guogui, Guo, Qisen, Ji, Youxin, Zhu, Xiaoli, Hu, Sheng, Zhang, Wei, Wang, Qiming, Jia, Yuming, Wang, Ziping, Song, Yong, Wu, Jingxun, Shi, Meiqi, Li, Xingya, Han, Zhigang, Liu, Yunpeng, Yu, Zhuang, Liu, An-Wen, Wang, Xiuwen, Zhou, Caicun, Zhong, Diansheng, Miao, Liyun, Zhang, Zhihong, Zhao, Hui, Yang, Jun, Wang, Dong, Wang, Yingyi, Li, Qiang, Zhang, Xiaodong, Ji, Mei, Yang, Zhenzhou, Cui, Jiuwei, Gao, Beili, Wang, Buhai, Liu, Hu, Nie, Lei, He, Mei, Jin, Shi, Gu, Wei, Shu, Yongqian, Zhou, Tong, Feng, Jian, Yang, Xinmei, Huang, Cheng, Zhu, Bo, Yao, Yu, Tang, Xiongwen, Yu, Jianjun, Maher, Ellen, Feng, Hui, Yao, Sheng, Keegan, Patricia, Wang, Jie
Publicado 2023